AKUMS - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.4
| Stock Code | AKUMS | Market Cap | 9,471 Cr. | Current Price | 602 ₹ | High / Low | 635 ₹ |
| Stock P/E | 81.3 | Book Value | 154 ₹ | Dividend Yield | 0.17 % | ROCE | 6.82 % |
| ROE | 4.93 % | Face Value | 2.00 ₹ | DMA 50 | 543 ₹ | DMA 200 | 509 ₹ |
| Chg in FII Hold | 0.24 % | Chg in DII Hold | -0.05 % | PAT Qtr | 17.1 Cr. | PAT Prev Qtr | 31.0 Cr. |
| RSI | 64.4 | MACD | 20.6 | Volume | 1,86,858 | Avg Vol 1Wk | 4,33,723 |
| Low price | 409 ₹ | High price | 635 ₹ | PEG Ratio | -4.00 | Debt to equity | 0.02 |
| 52w Index | 85.2 % | Qtr Profit Var | -38.1 % | EPS | 7.09 ₹ | Industry PE | 32.1 |
📊 Optimal Buy Price: 590–600 ₹ (near minor retracement zone)
💹 Profit-Taking Levels: 615–630 ₹ (short-term resistance)
🛑 Stop-Loss: 580 ₹
⏱️ Exit Strategy if Holding: Exit intraday if RSI falls below 60 or price fails to sustain above 600 ₹. Book profits if momentum drives price into 615–630 ₹ zone with strong volume confirmation. Exit early if intraday volume weakens below average and price slips under 590 ₹.
✅ Positive
- Trading above DMA 50 (543 ₹) and DMA 200 (509 ₹) — strong uptrend
- FII holding increased (+0.24%) showing foreign investor confidence
- MACD positive (20.6) indicates bullish momentum
- Debt-to-equity ratio at 0.02 — virtually debt-free
- EPS at 7.09 ₹ supports fundamentals
- 52-week index at 85.2% shows strong price recovery
⚠️ Limitation
- Quarterly PAT declined (17.1 Cr. vs 31.0 Cr.) — earnings contraction
- ROCE (6.82%) and ROE (4.93%) reflect weak efficiency
- High P/E of 81.3 compared to industry PE of 32.1 — premium valuation
- PEG ratio (-4.00) indicates poor growth prospects
- DII holding decreased (-0.05%) showing mixed sentiment
- Volume (1.86 lakh) below weekly average (4.33 lakh) — weak participation
📉 Company Negative News
- Quarterly profit variation (-38.1%) highlights earnings volatility
📈 Company Positive News
- EPS strength supports long-term fundamentals
- FII inflows reflect confidence in growth potential
🏭 Industry
- Pharmaceutical sector benefiting from consistent demand and regulatory support
- Peers trading at lower PE, making AKUMS relatively expensive
🔎 Conclusion
AKUMS shows moderate intraday potential with bullish MACD and price trend above key moving averages. However, weak ROCE/ROE, declining PAT, and premium valuation limit attractiveness. Suitable for cautious intraday buy near 590–600 ₹ with strict stop-loss at 580 ₹ and profit booking around 615–630 ₹.
For deeper context, you could expand this into a swing trade outlook, add sector benchmarking, or run a peer comparison to refine positioning.